Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response ; volume:23 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-6 ; date:12.2024
Molecular cancer ; 23, Heft 1 (11.10.2024), 1-6, 12.2024
- Urheber
-
Lim, Su Yin
Silva, Ines Pires da
Adegoke, Nurudeen A.
Lo, Serigne N.
Menzies, Alexander M.
Carlino, Matteo S.
Scolyer, Richard A.
Long, Georgina V.
Lee, Jenny H.
Rizos, Helen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-02146-0
- URN
-
urn:nbn:de:101:1-2412302102548.771205871084
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lim, Su Yin
- Silva, Ines Pires da
- Adegoke, Nurudeen A.
- Lo, Serigne N.
- Menzies, Alexander M.
- Carlino, Matteo S.
- Scolyer, Richard A.
- Long, Georgina V.
- Lee, Jenny H.
- Rizos, Helen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Imaging of tumour response to immunotherapy
Predicting cancer type from tumour DNA signatures
Unravelling mutational signatures with plasma circulating tumour DNA
HNSCC: tumour antigens and their targeting by immunotherapy
Blood matters: the hematological signatures of Coronavirus infection
APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
A role for immunotherapy: preventing macrophage anergy in the tumour environment
Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences